Upregulation of NUCKS1 in Lung Adenocarcinoma is Associated with a Poor Prognosis

Reference

• El-Aarag SA, Mahmoud A, Hashem MH, Abd Elkader H, Hemeida AE, ElHefnawi M. In silico identification of potential key regulatory factors in smoking-induced lung cancer. BMC Med Genomics. 2017; 710(1):40. doi:10.1186/s12920-017-0284-z.
   Google Scholar
• Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA: A Cancer J Clinic. 2010;60(5):277–300.
   PubMed Web of Science ®Google Scholar
• Shen H, Wang L, Ge X, Jiang C-F, Shi Z-M, Li D-M, et al. MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer. Oncotarget. 2016;7(15):20728–42. doi:10.18632/oncotarget.8011.
   PubMedGoogle Scholar
• Kikuchi A, Ishikawa T, Mogushi K, Ishiguro M, Iida S, Mizushima H, et al. Identification of NUCKS1 as a colorectal cancer prognostic marker through integrated expression and copy number analysis. Int J Cancer. 2013;132(10):2295–302. doi:10.1002/ijc.27911.
   PubMed Web of Science ®Google Scholar
• Zhu K, Zhang Z, Zhang H, Wang Z, Wang F. MiR-142-3p targeting NUCKS1 inhibits proliferation and invasion of pancreatic cancer cells. Artif Cells Nanomed Biotechnol. 2020;48(1):415–24. doi:10.1080/21691401.2019.1652629.
   PubMed Web of Science ®Google Scholar
• Xu J, Liu L, Ma R, Wang Y, Chen X, Liu H, et al. E2F1 induces KIF26A transcription and promotes cell cycle progression via CDK-RB-E2Fs feedback loop in breast cancer. Front Oncol. 2020;10:530933 doi:10.3389/fonc.2020.530933.
   PubMed Web of Science ®Google Scholar
• Sargent LM, Ensell MX, Ostvold A-C, Baldwin KT, Kashon ML, Lowry DT, et al. Chromosomal changes in high- and low-invasive mouse lung adenocarcinoma cell strains derived from early passage mouse lung adenocarcinoma cell strains. Toxicol Appl Pharmacol. 2008;233(1):81–91. doi:10.1016/j.taap.2008.01.031.
   PubMed Web of Science ®Google Scholar
• El-Aarag SA, Mahmoud A, Hashem MH, Abd Elkader H, Hemeida AE, ElHefnawi M, et al. In silico identification of potential key regulatory factors in smoking-induced lung cancer. BMC Med Genomics. 2017;10(1):1–11. doi:10.1186/s12920-017-0284-z.
   PubMedGoogle Scholar
• Grundt K, Haga IV, Aleporou-Marinou V, Drosos Y, Wanvik B, Østvold AC. Characterisation of the NUCKS gene on human chromosome 1q32.1 and the presence of a homologous gene in different species. Biochem Biophys Res Commun. 2004;323(3):796–801. doi:10.1016/j.bbrc.2004.08.153.
   PubMed Web of Science ®Google Scholar
• Ostvold AC, Holtlund J, Laland SG. A novel, highly phosphorylated protein, of the high-mobility group type, present in a variety of proliferating and non-proliferating mammalian cells. Eur J Biochem. 1985;153(3):469–75. doi:10.1111/j.1432-1033.1985.tb09325.x.
   PubMedGoogle Scholar
• Drosos Y, Kouloukoussa M, Ostvold AC, Havaki S, Katsantoni E, Marinos E, et al. Dynamic expression of the vertebrate-specific protein Nucks during rodent embryonic development. Gene Expr Patterns. 2014;14(1):19–29. doi:10.1016/j.gep.2013.10.001.
   PubMed Web of Science ®Google Scholar
• Ostvold AC, Norum JH, Mathiesen S, Wanvik B, Sefland I, Grundt K. Molecular cloning of a mammalian nuclear phosphoprotein NUCKS, which serves as a substrate for Cdk1 in vivo. Eur J Biochem. 2001;268(8):2430–40. doi:10.1046/j.1432-1327.2001.02120.x.
   PubMedGoogle Scholar
• Huang P, Cai Y, Zhao B, Cui L. Roles of NUCKS1 in Diseases: Susceptibility, Potential Biomarker, and Regulatory Mechanisms. Biomed Res Int. 2018;2018:7969068 doi:10.1155/2018/7969068.
   PubMed Web of Science ®Google Scholar
• Simón-Sánchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet. 2009;41(12):1308–12. doi:10.1038/ng.487.
   PubMed Web of Science ®Google Scholar
• Gu L, Xia B, Zhong L, Ma Y, Liu L, Yang L, et al. NUCKS1 overexpression is a novel biomarker for recurrence-free survival in cervical squamous cell carcinoma. Tumor Biol. 2014;35(8):7831–6. doi:10.1007/s13277-014-2035-5.
   PubMedGoogle Scholar
• Yang M, Wang X, Zhao Q, Liu T, Yao G, Chen W, et al. Combined evaluation of the expression of NUCKS and Ki-67 proteins as independent prognostic factors for patients with gastric adenocarcinoma. Tumour Biol. 2014;35(8):7505–12. doi:10.1007/s13277-014-1880-6.
   PubMedGoogle Scholar
• Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133(4):1710–5.
   PubMed Web of Science ®Google Scholar
• Zduniak K, Agrawal S, Symonowicz K, Jurczyszyn K, Ziółkowski P. The comparison of nuclear ubiquitous casein and cyclin-dependent kinases substrate (NUCKS) with Ki67 proliferation marker expression in common skin tumors. Pol J Pathol. 2014;65(1):48–54. doi:10.5114/pjp.2014.42669.
   PubMed Web of Science ®Google Scholar
• Symonowicz K, Duś-Szachniewicz K, Woźniak M, Murawski M, Kołodziej P, Osiecka B, et al. Immunohistochemical study of nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 in invasive breast carcinoma of no special type. Exp Ther Med. 2014;8(4):1039–46. doi:10.3892/etm.2014.1847.
   PubMed Web of Science ®Google Scholar
• Ziółkowski P, Gamian E, Osiecka B, Zougman A, Wiśniewski JR. Immunohistochemical and proteomic evaluation of nuclear ubiquitous casein and cyclin-dependent kinases substrate in invasive ductal carcinoma of the breast. J Biomed Biotechnol. 2009;2009:919645. doi:10.1155/2009/919645.
   PubMedGoogle Scholar
• Soliman NA, Zineldeen DH, El-Khadrawy OH. Effect of NUCKS-1 overexpression on cytokine profiling in obese women with breast cancer. Asian Pacific J Cancer Prevent. 2014;15(2):837–45. doi:10.7314/APJCP.2014.15.2.837.
   PubMedGoogle Scholar
• Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. The. N Engl J Med. 2007;356(3):217–26. doi:10.1056/NEJMoa063994.
   PubMed Web of Science ®Google Scholar
• Cheong JY, Kim YB, Woo JH, Kim DK, Yeo M, Yang S-J, et al. Identification of NUCKS1 as a putative oncogene and immunodiagnostic marker of hepatocellular carcinoma. Gene. 2016;584(1):47–53. doi:10.1016/j.gene.2016.03.006.
   PubMed Web of Science ®Google Scholar
• Parplys AC, Zhao W, Sharma N, Groesser T, Liang F, Maranon DG, et al. NUCKS1 is a novel RAD51AP1 paralog important for homologous recombination and genome stability. Nucleic Acids Res. 2015;43(20):9817–34. doi:10.1093/nar/gkv859.
   PubMed Web of Science ®Google Scholar
• Yuan X, Zhang M, Ao J, Zhen Z, Gao X, Li M. NUCKS1 is a novel regulator of milk synthesis in and proliferation of mammary epithelial cells via the mTOR signaling pathway. J Cell Physiol. 2019;234(9):15825–11. doi:10.1002/jcp.28240.
   PubMed Web of Science ®Google Scholar
• Maranon DG, Sharma N, Huang Y, Selemenakis P, Wang M, Altina N, et al. NUCKS1 promotes RAD54 activity in homologous recombination DNA repair. J Cell Biol. 2020;219(10):e201911049.
   PubMed Web of Science ®Google Scholar
• Huang Y-K, Kang W-M, Ma Z-Q, Liu Y-Q, Zhou L, Yu J-C. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway. Carcinogenesis. 2019;40(2):370–9. doi:10.1093/carcin/bgy142.
   PubMed Web of Science ®Google Scholar